Using a stool test to predict varices in cirrhosis
Part of Digestive system clinical trials.
This study checks if a simple stool test (fecal calprotectin) can help predict the presence of enlarged veins in the esophagus (varices) in people with cirrhosis. If successful, this could offer a non-invasive way to screen for this serious complication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a diagnosis of liver cirrhosis.
- You do not have inflammatory bowel disease (like Crohn's disease or ulcerative colitis).
- You do not have an active infection of the stomach or intestines.
- You are not currently being treated for any type of cancer.
- You are not taking medications called proton pump inhibitors (like omeprazole) or NSAIDs (like ibuprofen).
- You do not have spontaneous bacterial peritonitis (an infection in the belly fluid).
- You do not have hepatic encephalopathy (confusion caused by liver problems).
- You are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple ultrasound-based test (FibroScan) to check liver stiffness and predict whether you have high pressure in the veins around the liver. It aims to see if a new set of criteria can safely tell who needs an endoscopy, helping avoid unnecessary procedures.
This study looks for ways to predict if a child with portal hypertension (high blood pressure in the liver's blood vessels) has enlarged veins in the esophagus, without needing an endoscopy. It aims to use simple blood tests and spleen size to identify children who may need further monitoring.
This study uses ultrasound (sound wave imaging) to check your liver and veins to see if you are at risk for bleeding from enlarged veins in your food pipe. It may help find a safer, less invasive way to predict bleeding risk compared to routine endoscopy.
This study compares two ways to prevent future bleeding from enlarged veins in the esophagus or stomach in people with liver cirrhosis. One method uses a small tube (called TIPS) to reduce pressure in the liver, and the other combines a banding procedure with medication. The goal is to see which approach works better.
This study tests a new ultrasound method that measures spleen stiffness to help diagnose enlarged veins in the esophagus (esophageal varices) in people with chronic liver disease. It aims to find a less invasive way to detect these veins, which can cause serious bleeding.
This trial tests if a special ultrasound technique combined with liver stiffness and platelet count can predict which patients with cirrhosis have high-risk varices in the esophagus or stomach, potentially reducing the need for repeated endoscopy.
Hear when a new Esophageal Varices trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.